Prognosis and Treatment Strategies in Myelofibrosis: Risk Assessment and Therapeutic Goals
Aaron Gerds, MD, MS, explores myelofibrosis risk assessment, treatment goals, and therapeutic strategies, including JAK (Janus kinase inhibitors) inhibitors and transplant considerations.
Aaron Gerds Dynamic International Prognostic Scoring System Merit Based Incentive Payment System Myelofibrosis Secondary Prognostic Model Myeloproliferative Neoplasms
Source: ajmc.com